Adenocarcinoma is often associated with genetic mutations such as EGFR (epidermal growth factor receptor), ALK (anaplastic lymphoma kinase), and KRAS (Kirsten rat sarcoma viral oncogene homolog), making it a target for precision therapies [21]. Here, KRAS is linked to adenocarcinoma.